Wealthspire Advisors (New York)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-140,123
| Closed | -$1.06M | – | 618 |
|
|
2023
Q2 | $1.06M | Sell |
140,123
-10,000
| -7% | -$75.3K | 0.02% | 243 |
|
|
2023
Q1 | $1.33M | Sell |
150,123
-2,351
| -2% | -$20.8K | 0.02% | 202 |
|
|
2022
Q4 | $1.39M | Sell |
152,474
-67,649
| -31% | -$617K | 0.03% | 201 |
|
|
2022
Q3 | $1.78M | Buy |
220,123
+70,000
| +47% | +$565K | 0.04% | 157 |
|
|
2022
Q2 | $1.13M | Sell |
150,123
-170,000
| -53% | -$1.28M | 0.02% | 203 |
|
|
2022
Q1 | $3.01M | Buy |
320,123
+35,253
| +12% | +$331K | 0.07% | 99 |
|
|
2021
Q4 | $2.28M | Buy |
284,870
+142,519
| +100% | +$1.14M | 0.05% | 135 |
|
|
2021
Q3 | $1.39M | Buy |
+142,351
| New | +$1.39M | 0.03% | 208 |
|
|
2019
Q1 | – | Sell |
-16
| Closed | – | – | 707 |
|
|
2018
Q4 | $0 | Buy |
+16
| New | – | ﹤0.01% | 916 |
|